Actinium Return On Equity from 2010 to 2024
| ATNM Stock | USD 8.75 0.97 12.47% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter (1.34) | Current Value (1.27) | Quarterly Volatility 4.6160804 |
Check Actinium Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Actinium main balance sheet or income statement drivers, such as Selling General Administrative of 14 M, Other Operating Expenses of 54.6 M or Total Operating Expenses of 53.8 M, as well as many exotic indicators such as Price To Sales Ratio of 1.8 K, Dividend Yield of 0.0 or PTB Ratio of 3.9. Actinium financial statements analysis is a perfect complement when working with Actinium Pharmaceuticals Valuation or Volatility modules.
Actinium | Return On Equity |
Latest Actinium Pharmaceuticals' Return On Equity Growth Pattern
Below is the plot of the Return On Equity of Actinium Pharmaceuticals over the last few years. Return on Equity is the amount of Actinium Pharmaceuticals net income returned as a percentage of Actinium Pharmaceuticals equity. Return on equity measures Actinium Pharmaceuticals profitability by revealing how much profit Actinium Pharmaceuticals generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. Actinium Pharmaceuticals' Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Actinium Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported -0.92 | 10 Years Trend |
|
Return On Equity |
| Timeline |
Actinium Return On Equity Regression Statistics
| Arithmetic Mean | (0.12) | |
| Geometric Mean | 1.35 | |
| Coefficient Of Variation | (3,852) | |
| Mean Deviation | 2.74 | |
| Median | (0.96) | |
| Standard Deviation | 4.62 | |
| Sample Variance | 21.31 | |
| Range | 20.1395 | |
| R-Value | (0.21) | |
| Mean Square Error | 21.93 | |
| R-Squared | 0.04 | |
| Significance | 0.45 | |
| Slope | (0.22) | |
| Total Sum of Squares | 298.31 |
Actinium Return On Equity History
About Actinium Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Actinium Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Actinium Pharmaceuticals investors use historical funamental indicators, such as Actinium Pharmaceuticals's Return On Equity, to determine how well the company is positioned to perform in the future. Although Actinium Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Actinium Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Actinium Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Actinium Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Actinium Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Equity | (1.34) | (1.27) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Actinium Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Actinium Pharmaceuticals' short interest history, or implied volatility extrapolated from Actinium Pharmaceuticals options trading.
Pair Trading with Actinium Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Actinium Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actinium Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Actinium Stock
| 0.72 | VKTX | Viking Therapeutics | PairCorr |
| 0.67 | DYAI | Dyadic International Financial Report 8th of May 2024 | PairCorr |
Moving against Actinium Stock
| 0.59 | GNLX | Genelux Common | PairCorr |
| 0.57 | OVID | Ovid Therapeutics Financial Report 3rd of May 2024 | PairCorr |
| 0.52 | ORGO | Organogenesis Holdings Earnings Call This Week | PairCorr |
| 0.49 | EWTX | Edgewise Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.48 | GNFT | Genfit | PairCorr |
The ability to find closely correlated positions to Actinium Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Actinium Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Actinium Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Actinium Pharmaceuticals to buy it.
The correlation of Actinium Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Actinium Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Actinium Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Actinium Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Actinium Pharmaceuticals Correlation against competitors. To learn how to invest in Actinium Stock, please use our How to Invest in Actinium Pharmaceuticals guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Actinium Stock analysis
When running Actinium Pharmaceuticals' price analysis, check to measure Actinium Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinium Pharmaceuticals is operating at the current time. Most of Actinium Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Actinium Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinium Pharmaceuticals' price. Additionally, you may evaluate how the addition of Actinium Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Actinium Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Actinium Pharmaceuticals. If investors know Actinium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Actinium Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.71) | Revenue Per Share 0.003 | Quarterly Revenue Growth (1.00) | Return On Assets (0.33) | Return On Equity (0.92) |
The market value of Actinium Pharmaceuticals is measured differently than its book value, which is the value of Actinium that is recorded on the company's balance sheet. Investors also form their own opinion of Actinium Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Actinium Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Actinium Pharmaceuticals' market value can be influenced by many factors that don't directly affect Actinium Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Actinium Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Actinium Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Actinium Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.